Floatz logo

Napazimone

Mitochondrial Myopathies

Abliva ABSmall moleculePhase 1Dormant
CC
47/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
32/ 100
Competitive Position
95/ 100

Competitive context

2 Active assets in the Mitochondrial Myopathies cohort.

Asset / SponsorPhaseRating
Sonlicromanol
Khondrion BV
Phase 2B
Doxecitine
Cristina Domínguez González
Phase 2CCC
1-(2-Deoxy-?-D-erythro-pentofuranosyl)-5-methyl-2,4(1H,3H)-pyrimidinedione
Cristina Domínguez González
Phase 2CCC
Thioctic Acid
National Center for Research Resources (NCRR)
N/ANR

Same molecule, other indications

Napazimone is also rated in:

mitochondrial diseaseDormant
CCC
Indicative ·
52 / 100
View asset →
MELAS syndromeDormant
CCC
Indicative ·
52 / 100
View asset →
Mitochondrial Respiratory Chain DeficienciesDormant
CCC
Indicative ·
52 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →